Evidence map›Paper›PMID 31819417›Full record

ArticleInternational journal of nanomedicine2019

Enhanced Anti-Bacterial Activity Of Biogenic Silver Nanoparticles Synthesized From

Michele Stella Majoumouo, Nicole Remaliah Samantha Sibuyi, Marius Belmondo Tincho, Michele Mbekou, Fabrice Fekam Boyom, Mervin Meyer

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 79 citations in OpenAlex.

  1. Article
  2. Article
  3. Cytotoxic Effects ofAnti-cancer agents in medicinal chemistry · 2025
    Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Biosorption ofGels (Basel, Switzerland) · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Synergistic and antibiofilm potential ofFrontiers in chemistry · 2022
    Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Michele Stella MajoumouoAntimicrobial & Biocontrol Agents Unit, Laboratory for Phytobiochemistry and Medicinal Plants Studies, Department of Biochemistry, University of Yaoundé 1, Yaoundé, Cameroon.ORCID 0000-0001-7639-6855
Nicole Remaliah Samantha SibuyiDepartment of Science and Technology (DST)/Mintek Nanotechnology Innovation Centre, Biolabels Node, Department of Biotechnology, University of the Western Cape, Bellville, South Africa.ORCID 0000-0001-7175-5388
Marius Belmondo TinchoDepartment of Science and Technology (DST)/Mintek Nanotechnology Innovation Centre, Biolabels Node, Department of Biotechnology, University of the Western Cape, Bellville, South Africa.ORCID 0000-0002-1293-5933
Michele MbekouAntimicrobial & Biocontrol Agents Unit, Laboratory for Phytobiochemistry and Medicinal Plants Studies, Department of Biochemistry, University of Yaoundé 1, Yaoundé, Cameroon.
Fabrice Fekam BoyomAntimicrobial & Biocontrol Agents Unit, Laboratory for Phytobiochemistry and Medicinal Plants Studies, Department of Biochemistry, University of Yaoundé 1, Yaoundé, Cameroon.ORCID 0000-0002-3147-364X
Mervin MeyerDepartment of Science and Technology (DST)/Mintek Nanotechnology Innovation Centre, Biolabels Node, Department of Biotechnology, University of the Western Cape, Bellville, South Africa.ORCID 0000-0002-8296-4860
Mintek · ZAUniversité de Yaoundé I · CM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe global increase in outbreaks and mortality rates associated with multi-drug-resistant (MDR) bacteria is a major health concern and calls for alternative treatments. Natural-derived products have shown potential in combating the most dreadful diseases, and therefore serve as an effective source of bioactive compounds that can be used as anti-bacterial agents. These compounds are able to reduce metal ions and cap nanoparticles to form biogenic nanoparticles (NPs) with remarkable anti-bacterial activities. This study explores the use of

methodsTM-AgNPs were synthetized by the reduction of AgNO

resultsPolycrystalline biogenic AgNPs with anisotropic shapes and diameter range of 11 to 83 nm were synthesized from the TM extracts. The biogenic TM-AgNPs showed significant antibacterial activity compared to their respective extracts. The MIC values for TM-AgNPs and extracts were 3 and 125 µg/mL, respectively. Biogenic AgNPs synthesised from the aqueous TM leaf extract at 25°C (

conclusionThis study demonstrated the ability of TM extracts to synthesize biogenic AgNPs. The NPs synthesized from the aqueous TM extracts demonstrated higher antibacterial activity against the tested microorganisms compared to the methanolic extracts. Studies are underway to identify the phytochemicals involved in NP synthesis and their mechanism of action.

Indexed as

Anti-Bacterial AgentsBacteriaDrug Resistance, Multiple, BacterialDynamic Light ScatteringMetal NanoparticlesMicrobial Sensitivity TestsPlant ExtractsSilverSpectrophotometry, UltravioletSpectroscopy, Fourier Transform InfraredTerminaliaAnti-Bacterial AgentsPlant ExtractsSilverantibacterial activityantimicrobial resistancegreen synthesisnanotechnologyTerminalia mantaly

Identifiers

PMID31819417
PMCPMC6875292
OpenAlexW2983381785

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.